Navigation Links
FDA Approves Erbitux to Treat Late-stage Head and Neck Cancer
Date:11/7/2011

SILVER SPRING, Md., Nov. 7, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Erbitux (cetuximab) for use with chemotherapy to treat patients with late-stage (metastatic) head and neck cancer.

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

Combined with chemotherapy, Erbitux extended the lives of those receiving the treatment combination compared with those receiving chemotherapy alone. Erbitux already is FDA-approved for certain types of colon cancer, and has been approved since 2006 for treatment of non-metastatic head and neck cancer in combination with radiation therapy (first-line) or as a single agent (following standard treatment).

According to the National Cancer Institute, head and neck cancers account for 3 percent to 5 percent of all cancers in the United States. These cancers typically develop in the nose, throat or mouth and they are more common in men and in people older than 50.

"Erbitux's ability to extend the lives of patients with head and neck cancers is an important tool for oncologists who often rely on a multi-treatment approach for patients," said Richard Pazdur, M.D., director of the Office of Hematology and Oncology Drug Products in the FDA's Center for Drug Evaluation and Research." Given the aggressive nature of head and neck cancers that cannot be treated with surgery and radiation, it is important that patients have as many treatment options available as possible."

The safety and effectiveness of Erbitux for this indication is based on the results of a multi-center clinical study conducted outside the United States involving 442 patients with metastatic or recurrent head and neck cancer. The study used a non-U.S. approved version of cetuximab, rather than the U.S.-approved formulation.

Participants had inoperable or widespread disease and had not received prior chemotherapy. Half
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Approves Xarelto to Prevent Stroke in People With Common Type of Abnormal Heart Rhythm
2. FDA Approves U.S. Market Return for octagam® Following Octapharmas Implementation of Enhanced Safety Measures
3. FDA Approves First Artificial Aortic Heart Valve Placed Without Open-Heart Surgery
4. FDA Approves First Generic Olanzapine to Treat Schizophrenia, Bipolar Disorder
5. FDA Approves Onfi To Treat Severe Type of Seizures
6. FDA Approves Longer Duration Efficacy and Safety for EUFLEXXA®
7. FDA Approves Label Update for PREZISTA® to Include 192-Week Data in HIV-1-Infected Adult Patients Starting Treatment
8. FDA Approves Ferriprox to Treat Patients with Excess Iron in the Body
9. FDA Approves Combination Therapy Juvisync
10. FDA Approves Cialis to Treat Benign Prostatic Hyperplasia
11. FDA Approves Remicade to Treat Ulcerative Colitis in Children Older Than 6 Years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... May 24, 2013  Auxilium Pharmaceuticals, Inc. (Nasdaq: ... participate in the Deutsche Bank Health Care Conference to ... Hotel.  Mr. Adrian Adams , Chief ... overview of the Company and its product pipeline at ... (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) The ...
(Date:5/24/2013)... May 24, 2013 The potential ... systemic delivery of therapeutic agents has been receiving undeniable ... delivery showing significant promise. The crucial formulation considerations for ... device play a major role in the efficiency of ... the development of new formulation techniques and devices in ...
(Date:5/23/2013)...  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ) ... Life Science Firm of the Year by the Tech Council ... at the TCM,s 25 th Annual Tech Awards Celebration ... Awards Celebration recognizes the leaders and innovators in the technology ... and the surrounding regions. "We are deeply ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2
... 2011 With the support of Key Opinion Leaders ... the time and attention of KOLs is intensifying. But ... landscape for creating and maintaining KOL and physician relationships. ... KOL landscape, Best Practices, LLC has published an updated ...
... Endo Pharmaceuticals (Nasdaq: ENDP ) announced today ... of President, HealthTronics Inc., effective Aug. 29, 2011. HealthTronics, ... urological products and services based in Austin, Texas. ... HealthTronics Group President James Whittenburg, who is staying through ...
Cached Medicine Technology:Pharma Medical Science Liaison Outreach Shifting Away from Traditional Company Sales Regions 2Endo Pharmaceuticals Announces Leadership Change at HealthTronics Subsidiary: Appoints Kelly Huang, Ph.D. New President 2Endo Pharmaceuticals Announces Leadership Change at HealthTronics Subsidiary: Appoints Kelly Huang, Ph.D. New President 3
(Date:5/25/2013)... It's not astonishing that holidays are ... demands are endless, from family, friends and co-workers. Between ... want more than their parents can afford, parties to ... comes graduations, birthdays, anniversaries and it seems like an ... ideas become tired and income can’t catch up to ...
(Date:5/25/2013)... Coral Springs, FL (PRWEB) May 25, 2013 ... for Dallas-Ft. Worth, Texas. It is the fifth largest media ... homes. Dallas is the number one visitor destination in Texas ... the cultural gateway to the American West as it is ... of activities everyone will enjoy from sports to the arts. ...
(Date:5/25/2013)... make great companions for senior citizens, but elderly people who ... more likely to crash than those who never drive with ... 2,000 licensed drivers aged 70 and older. The nearly 700 ... with their pet in the car. Among those who ... as high as among those who never drove with their ...
(Date:5/25/2013)... Louis, MO (PRWEB) May 25, 2013 Providing ... for the Diet Doc team of weight management professionals. But, ... fast and effectively, Diet Doc’s hCG diets ... factors like abuse during childhood like bullying, more control over ... directly capable of dealing with the underlying factors of weight ...
(Date:5/25/2013)... The latest report from BetterDigestion.org ... syndrome (IBS) to bloating, constipation, diarrhea and other ... embarrassing, frustrating and difficult health issues to resolve. ... have provided a cure for these troublesome ... to digestive health issues, a healthy diet is ...
Breaking Medicine News(10 mins):Health News:TheBeautyPlace.com Debuts Their Brand New Beauty Kits 2Health News:Communities of Distinction TV Presents May Air Dates for Dallas-Ft. Worth, Texas 2Health News:Seniors More Likely to Crash When Driving With Pet: Study 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 3Health News:Natural Foods For Digestive Health Report and Video Published by BetterDigestion.org 2
... medical care in Korea but can afford it least ... services, according to a Yale School of Medicine ... ,Low-income individuals with multiple chronic conditions ... because they need and use more services, said Jennifer ...
... been clearly described, but a new study from researchers ... a strong association between domestic violence and asthma. ... International Journal of Epidemiology, raises questions about the role ... condition. ,"Classic environmental triggers for asthma ...
... candidates on Thursday in their first televised debate -- ... Valley , Calif. -- fielded questions about their ... issues, the Washington Post reports. ,The ... Brownback (Kan.); former New York City Mayor Rudolph Giuliani; ...
... More research is needed to determine the true effects ... fetus, and the impact on pregnant women of ... researchers say. ,Recommendations for safe levels ... between states and organisations in Australia, according to new ...
... in health services between rural and metropolitan areas, according ... failure is an increasing public health problem in developed ... of the highest population growths in the over-65 years ... are evident for rural and remote Australians for many ...
... the pollution of the river Yamuna is a major problem. ... days. It was possible some years ago," Indian Space Research ... address at Dayalbagh University here. ,"The prevailing ... hands. I wonder why people are not alarmed and concerned ...
Cached Medicine News:Health News:Poor and Chronically Ill in Korea Pay More for Healthcare 2Health News:Research Demonstrates Link Between Domestic Violence and Asthma 2Health News:Republican Presidential Candidates Discuss Abortion, Stem Cells as Part of First Debate 2Health News:Better Research Needed On Alcohol In Pregnancy 2
... a whole blood control for evaluating the ... measure automated blood cell counts in patient ... RBC and WBC values for the Abbott ... LH750/LH 755 (levels 2 and 3 only) ...
iSleep 20i is an advanced high performance CPAP with outstanding self-adjusting i‑technology....
Spectrum Dynamics empowers Nuclear Imaging with the SmartR Technology,of the D-SPECT Cardiac Imaging System. The D-SPECT is powered by BroadView Technology to provide unprecedented throughput, whil...
Diagnosoft HARP is designed for rapid analysis of tagged cardiac MR images using the HARP technology, which is packaged into an intuitive, easy-to-use graphic user interface....
Medicine Products: